Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.44 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.40 |
| ▸ | LCK | P06239 | 1/20 | 0.40 |
| ▸ | PPARD | Q03181 | 1/20 | 0.40 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.40 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.40 |
| ▸ | FAAH | O00519 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2803737 | 1.00 | ZDHHC7 (0.44) | ZDHHC7GPR84FFAR1MAPTCPB2 | |
| SCHEMBL4119282 | 0.98 | ZDHHC7 (0.42) | ZDHHC7GPR84FFAR1MAPTCPB2 | |
| Acetic Acid SCHEMBL9301447 | 0.95 | GPR84 (0.42) | ZDHHC7GPR84FFAR1MAPTCPB2 | |
| SCHEMBL7070785 | 0.88 | ZDHHC7 (0.50) | ZDHHC7GPR84FFAR1MAPTCPB2 | |
| SCHEMBL19690704 | 0.88 | ZDHHC7 (0.50) | ZDHHC7GPR84FFAR1MAPTCPB2 | |
| SCHEMBL6772533 | 0.88 | GPR84 (0.42) | ZDHHC7GPR84FFAR1MAPTCPB2 | |
| SCHEMBL13269368 | 0.86 | ZDHHC7 (0.47) | ZDHHC7GPR84FFAR1MAPTCPB2 | |
| SCHEMBL17713606 | 0.83 | ZDHHC7 (0.46) | ZDHHC7GPR84FFAR1MAPTCPB2 | |
| SCHEMBL2535153 | 0.81 | LMNA (0.45) | ZDHHC7GPR84FFAR1MAPTCPB2 | |
| SCHEMBL29186605 | 0.81 | GPR84 (0.46) | ZDHHC7GPR84FFAR1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 283 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118243809-A | Method for determining chloronitrobenzene monomer carbon stable isotope and application thereof | 广东工业大学 | 2024-06-25 | — | — | CN | claimed |
| CN-116621882-A | Platinum-based bowl phosphine complex, fullerene array thereof, preparation and application thereof | 广西师范大学 | 2023-08-22 | — | — | CN | claimed |
| CN-118243809-A | Method for determining chloronitrobenzene monomer carbon stable isotope and application thereof | 广东工业大学 | 2024-06-25 | — | — | CN | disclosed |
| US-RE49918-E1 | Cytotoxic benzodiazepine derivatives | IMMUNOGEN, INC. (US) | 2024-04-16 | — | — | US | disclosed |
| US-20230346943-A1 | SPACER-MEDIATED CONTROL OF UNCAGING PHOTOCAGED MOLECULES | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2023-11-02 | — | — | US | disclosed |
| CN-116621882-A | Platinum-based bowl phosphine complex, fullerene array thereof, preparation and application thereof | 广西师范大学 | 2023-08-22 | — | — | CN | disclosed |
| CN-115836062-A | Compound and medical application thereof | 心悦生医股份有限公司 | 2023-03-21 | — | — | CN | disclosed |
| CN-114113372-A | Method for detecting residual solvent of natural edible pigment | 拱北海关技术中心 | 2022-03-01 | — | — | CN | disclosed |
| WO-2021150621-A1 | SPACER-MEDIATED CONTROL OF UNCAGING PHOTOCAGED MOLECULES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-07-29 | — | — | WO | disclosed |
| EP-3666289-A1 | CYTOTOXIC BENZODIAZEPINE DERIVATIVES | ImmunoGen, Inc. (US) | 2020-06-17 | — | — | EP | disclosed |
| US-10647737-B2 | Sulfated-glycolipids as adjuvants for vaccines | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2020-05-12 | — | — | US | disclosed |
| WO-1998002441-A2 | NON IMMUNOSUPPRESSIVE ANTIFUNGAL RAPALOGS | ARIAD PHARMACEUTICALS, INC. (US) | 1998-01-22 | — | — | WO | disclosed |
| WO-1997026240-A1 | CONFORMATIONALLY RESTRICTED AROMATIC INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND METHOD | BRISTOL-MYERS SQUIBB COMPANY (US) | 1997-07-24 | — | — | WO | disclosed |
| WO-1997014697-A1 | THIENOPYRIDINE DERIVATIVES AS GONADOTROPIN RELEASING HORMONE ANTAGONISTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-04-24 | — | — | WO | disclosed |
| WO-1997009328-A1 | PHENYLOXAZOLIDINONES HAVING A C-C BOND TO 4-8 MEMBERED HETEROCYCLIC RINGS | PHARMACIA & UPJOHN COMPANY (US) | 1997-03-13 | — | — | WO | disclosed |
| EP-0512352-B1 | Substituted carboxylic acid derivatives | HOFFMANN LA ROCHE (CH) | 1996-03-27 | — | — | EP | disclosed |
| US-5344843-A | Carnitine acryltransferase enzyme inhibitors as antiischemic agents and for cardiovascular disorders | HOFFMAN-LA ROCHE INC. (US) | 1994-09-06 | — | — | US | disclosed |
| EP-0512352-A2 | Substituted carboxylic acid derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1992-11-11 | — | — | EP | disclosed |
| US-5104883-A | Cardiovascular, respiratory, gastrointestirol, urogenital disorders; baldness; premature labor | MAY & BAKER LIMITED (GB) | 1992-04-14 | — | — | US | disclosed |
| US-4481144-A | 17-Substituted thia-17-alkyl(or alkenyl or alkynyl)androstenes | E. R. SQUIBB & SONS, INC. (US) | 1984-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230346943-A1 | SPACER-MEDIATED CONTROL OF UNCAGING PHOTOCAGED MOLECULES | DCLRE1A, PCNA, HMBS | ZDHHC7 1226/4885GPR84 3340/4885FFAR1 4311/4885 |
| US-10647737-B2 | Sulfated-glycolipids as adjuvants for vaccines | DEGS1, SGMS1, CD4 | ZDHHC7 892/4885GPR84 3243/4885FFAR1 661/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.